Abstract
As a result of the AYA age range adopted by the US National Cancer Institute Progress Review Group, the authors of this second edition have risen to the challenge of extending the upper age limit from 29 to 39 years. This has uncovered some unanticipated revelations, especially in the realms of epidemiology and biology. For example, in the former, a remarkable and hitherto unknown incidence of prostate cancer in young adults has come to light, while in the latter, the age-related trajectory of characteristics that typify cancers in the AYA population has been expanded to bridge the gap between adolescents and older adults, as in acute lymphoblastic leukemia (ALL) and colorectal cancers. Another important finding is the overdiagnosis of some cancers in AYAs, as best evidenced by renal and thyroid carcinomas. These data have been amplified in the chapters on individual diseases.
This is a preview of subscription content, log in via an institution.
Buying options
Tax calculation will be finalised at checkout
Purchases are for personal use only
Learn about institutional subscriptionsReferences
Albritton K, Barr R, Bleyer A (2010) The adolescence of young adult oncology. Semin Oncol 36:478–488
Pui C-H, Yang JJ, Hunger SP et al (2015) Childhood acute lymphoblastic leukemia: progress through collaboration. J Clin Oncol 33:2938–2948
Freyer DR, Seibel NL (in press) The clinical trials gap for adolescents and young adults with cancer: recent progress and conceptual framework for continued research. Curr Pediatr Rep. doi:10.1007s40124-0075-y
Fern LA, Lewandowski JA, Coxon KM et al (2014) Available, accessible, aware, appropriate, and acceptable: a strategy to improve participation of teenagers and young adults in cancer trials. Lancet Oncol 15:e341–e350
Weiss AR, Nichols CR, Freyer DR (2015) Enhancing adolescent and young adult oncology research within the National Clinical Trials Network: rationale, progress and emerging strategies. Semin Oncol 42:740–747
Wilkins KL, D’Agostino N, Penney AM, Barr RD, Nathan PC (2014) Supporting adolescents and young adults with cancer through transitions: position statement from the Canadian Task Force on adolescents and young adults with cancer. J Pediatr Hematol Oncol 36:545–551
Woodruff TK (2007) The emergence of a new interdiscipline: oncofertility. Cancer Treat Rep 138:3–11
Yabroff KR, Dowling EC, Guy GP Jr et al (2016) Financial hardship associated with cancer in the United States: findings from a population-based sample of adult cancer survivors. J Clin Oncol. Pii; JCO620468 34:259–267
Light DW, Kantarjian H (2013) Market spiral pricing of cancer drugs. Cancer 119:3900–3902
Conti RM, Padula WV, Larson RA (2015) Changing the cost of care for chronic myeloid leukemia: the availability of generic imatinib in the USA and the EU. Ann Hematol 94(Suppl 2):S249–S257
LaMontagne C (2015) NerdWallet Health finds medical bankruptcy accounts for majority of personal bankruptcies. http://www.nerdwallet.com/blog/health/medical-bills/nerdwallet-health-study-estimates-56-million-americans-65-struggle-medical-bills-2013. Accessed 29 Dec 2015
Tefferi A, Kantarjian H, Rajkumar SV et al (2015) In support of a patient-driven initiative and petition to lower the high price of cancer drugs. Mayo Clin Proc 90:996–1000
Martin S, Ulrich C, Munsell M, Taylor S, Lange G, Bleyer A (2007) Delays in cancer diagnosis in under-insured young adults and older adolescents. Oncologist 12:816–824
Wessler JM, Crouch G, Bleyer A, Merino M (2010) Lagtime to oncologic diagnoses: a comparison between military and non-military health care systems. Pediatr Blood Cancer 54: Abstr 195
Robbins AS, Lerro CC, Barr RD (2014) Insurance status and distant-stage disease among adolescent and young adult patients with cancer aged 15–39 years. National Cancer Database, 2004 through 2010. Cancer 120:1212–1219
Bleyer A, Ulrich C, Martin S (2012) Young adults, cancer, health insurance, socioeconomic status and the Patient Protection and Affordable Care Act. Cancer 118:6018–6021
Zebrack BJ, Corbett V, Embry L et al (2014) Psychological distress and unsatisfied need for psychosocial support in adolescent and young adult cancer patients during the first year following diagnosis. Psychooncology 23:1267–1275
Zebrack BJ, Block R, Hayes-Lattin B et al (2013) Psychosocial service use and unmet need among recently diagnosed adolescent and young adult cancer patients. Cancer 119:201–214
Recklitis CJ, Blackmon JE, Chang G (2016) Screening young adult cancer survivors for distress with the distress thermometer: comparisons with a structured clinical diagnostic interview. Cancer 122:296–303
Bhatia S, Landier W, Shangguan M et al (2012) Nonadherence to oral mercaptopurine and risk of relapse in Hispanic and non-Hispanic white children with acute lymphoblastic leukemia. A report from the Children’s Oncology Group. J Clin Oncol 30:2094–2101
Ganesan P, Sagar TG, Dubashi B et al (2011) Nonadherence to imatinib adversely affects event-free survival in chronic phase chronic myeloid leukemia. Am J Hematol 86:471–474
Kremelke K, Juergens C, Alz H, Reinhardt D (2015) Patients’ adherence in the maintenance therapy of children and adolescents with acute lymphoblastic leukemia. Klin Padiatr 227:326–334
Landier W, Chen Y, Hageman L et al (2015) 6-Mercaptopurine intake during maintenance for childhood acute lymphoblastic leukemia – a comparison of self-report and electronic monitoring. A report from the Children’s Oncology Group study AALL03N1. Ann Manag Am Soc Hematol Abstr 82
Anderson KR, Chambers CR, Lam N et al (2015) Medication adherence among adults prescribed dasatinib or nilotinib for the treatment of chronic myeloid leukemia. J Oncol Pharm Pract 21:19–25
Osborn M, Little C, Bowering S, Orme L (2013) Youth cancer services in Australia. Development and implementation. J Adolesc Young Adult Oncol 2:118–124
Fern L, Whelan J (2013) National Cancer Research Institute Teenage and Young Adult Clinical Studies Group: the United Kingdom approach to research. J Adolesc Young Adult Oncol 2:161–165
Johnson RH (2013) AYA in the USA. J Adolesc Young Adult Oncol 2:167–174
Zebrack B, Mathews-Bradshaw B, Siegel S (2010) Quality cancer care for adolescents and young adults: a position statement. J Clin Oncol 28:4862–4867
Hayes-Lattin B, Mathews-Bradshaw B, Siegel S (2010) Adolescent and young adult oncology training for health professionals: a position statement. J Clin Oncol 28:4858–4861
Nass SJ, Beaupin LJ, Demark-Wahnefried W et al (2015) Identifying and addressing the needs of adolescents and young adults with cancer: summary of an Institute of Medicine workshop. Oncologist 20:186–195
Keegan THM, Lichtensztajn DY, Kato I et al (2012) Unmet adolescent and young adult cancer survivors information and service needs: a population-based cancer registry study. J Cancer Surviv 6:239–250
Tai E, Buchanan N, Townsend J et al (2012) Health status of adolescent and young adult cancer survivors. Cancer 118:4884–4891
Guy GP Jr, Ekwueme DU, Yabroff KR et al (2013) Economic burden of cancer survivorship among adults in the United States. J Clin Oncol 31:3749–3757
Barr RD, Holowaty EJ, Birch JM (2006) Classification schemes for tumors diagnosed in adolescents and young adults. Cancer 106:1425–1430
Barr RD, Ferrari A, Ries L, Whelan J, Bleyer WA (2016) A narrative review of cancer in adolescents and young adults. Current status and a view of the future. JAMA Pediatr 170;495–501
Institute for Health Metrics and Evaluation (IHME) (2015) GBD compare. IHME, University of Washington, Seattle, Available from http://vizhub.healthdata.org/gbd-compare. Accessed 20 Jan 2016
Ferrari A, Thomas D, Franklin ARK et al (2010) Starting an adolescent and young adult program: some success stories and some obstacles to overcome. J Clin Oncol 28:4850–4857
Barr RD, Ries LAG, Lewis DR, Harlan LC, Keegan THM, Pollock BR, Bleyer A, for the U.S. National Cancer Institute Next Steps for Adolescent and Young Adult Oncology Epidemiology Working Group (2016) U.S. incidence and incidence trends of the most frequent cancers in adolescent and young adult Americans, including “non-malignant” tumors. Cancer 122;1000–1008
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2017 Springer International Publishing
About this chapter
Cite this chapter
Barr, R.D., Ries, L., Ferrari, A., Whelan, J., Bleyer, A. (2017). Conclusions, Perspectives, and Future Considerations. In: Bleyer, A., Barr, R., Ries, L., Whelan, J., Ferrari, A. (eds) Cancer in Adolescents and Young Adults. Pediatric Oncology. Springer, Cham. https://doi.org/10.1007/978-3-319-33679-4_35
Download citation
DOI: https://doi.org/10.1007/978-3-319-33679-4_35
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-319-33677-0
Online ISBN: 978-3-319-33679-4
eBook Packages: MedicineMedicine (R0)